✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Suven Life Sciences Ltd.

SUVEN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹6,059 Cr.
P/E
0.00

Suven Life Sciences Ltd.

  • Suven Life Sciences
  • Hikal
  • Piramal Pharma
  • TJI Pharma - Small Cap
FAQs on Suven Life Sciences Ltd. Shareprice

Suven Life Sciences has given better returns compared to its competitors.
Suven Life Sciences has grown at ~107.44% over the last 2yrs while peers have grown at a median rate of 6.3%

There is insufficient historical data to gauge this.
Latest PE of Suven Life Sciences is 0

View FAQ's On Business
Growth Table
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Balance Sheet
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Cash Flow
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Quarterly Results
  • Suven Life Sciences Ltd.
  • Hikal
  • Piramal Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Suven Life Sciences Ltd. Financials

Balance sheet of Suven Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Suven Life Sciences is increasing.
Latest net debt of Suven Life Sciences is -₹75.44 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹327.94 Crs.

The profit is oscillating.
The profit of Suven Life Sciences is -₹160.75 Crs for Mar 2025, -₹105.08 Crs for Mar 2024 and -₹118.27 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Suven Life Sciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech